Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias

Details for Australian Patent Application No. 2009222548 (hide)

Owner AstraZeneca AB

Inventors Ponten, Fritiof; Bjore, Annika; Kajanus, Johan; Olsson, Christina; Gran, Ulrik; Bonn, Peter

Agent Davies Collison Cave

Pub. Number AU-A-2009222548

Parent 2005254924

Filing date 2 October 2009

Wipo publication date 22 October 2009

International Classifications

C07D 498/08 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

22 October 2009 Application Open to Public Inspection

  Published as AU-A-2009222548

22 October 2009 Complete Application Filed

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009222549-Traffic Signal

2009222547-Immunotherapy of B cell malignancies and autoimmune disease using unconjugated antibodies and conjugated antibodies, antibody combinations and fusion proteins